XACT Robotics, a radiology technology company with offices in the United States and Israel, raised $36 million in its latest financing round.
The funds are expected to go toward commercializing the company’s FDA-cleared hands-free robotic system, which allows users to plan and navigate various instruments through the use of medical imaging.
“As we continue to build momentum for our robotic system, we will use the recent funding to launch the system to select U.S. radiology Centers of Excellence partners,” Chen Levin, CEO of XACT Robotics, said in a prepared statement. “In addition, we will invest to continue expanding the utilization of the system and support our future launch cycle, including compatibility of the XACT Robotic System with additional imaging modalities and clinical applications to address a broad range of patient care needs.”
Chasing Value Asset Management, Mazor Robotics and Corindus Vascular Robotics all contributed to the financing round, joining existing shareholders such as Shizim Group and MEDX Ventures Group.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.